Visual acuity poorly linked to GT after DSAEK

Article

Visual acuity poorly correlates to graft thickness (GT) in patients who underwent descemet stripping automated endothelial keratoplasty (DSAEK), states a paper in the journal Cornea.

Visual acuity poorly correlates to graft thickness (GT) in patients who underwent descemet stripping automated endothelial keratoplasty (DSAEK), states a paper in the journal Cornea.

Dr Maria Woodward et al., Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA, performed a retrospective chart review on 64 eyes of 52 patients who had anterior segment OCT imaging. The group obtained donor tissue characteristics and clinical information the eye bank and medical records, respectively.

Mean GT decreased from 199±45 μm to 165±53 μm , meaning there was a moderate correlation with preoperative and postoperative GT. Mean Snellen visual acuity was 20/28 at one year and 20/29 at the final follow up visit.

There was poor correlation between best-corrected visual acuity (BCVA) at the final visit and preoperative/postoperative GT. At the final follow up multivariate linear regression analysis demonstrated no relation of either postoperative GT or BCVA with donor tissue endothelial cell density, death-to-preservation time, death-to-surgery time, donor age, patient age or length of postoperative follow-up.

Please click here to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.